TickerLeague

Operating Income for IQVIA (IQV)

According to IQVIA's latest reported financial statements, the company's current operating income (TTM) is $2.29B USD. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

TTM (last 4 quarters)

$2.29B

YoY change

+3.9%

5Y CAGR

+25.6%

Peak year (2025)

$2.29B

Cumulative operating income

$16.10B

Operating Income history chart for IQVIA (IQV) from 2010 to 2025

Operating Income history table for IQVIA (IQV) from 2010 to 2025

Fiscal yearPeriod endedReportedOperating IncomeYoY
2025$2.29B+3.9%
2024$2.20B+11.4%
2023$1.98B+9.9%
2022$1.80B+29.1%
2021$1.39B+90.6%
2020$731.00M-5.9%
2019$777.00M+4.9%
2018$741.00M+3.1%
2017$719.00M+12.0%
2016$642.00M-0.7%
2015$646.61M+9.5%
2014$590.39M+27.7%
2013$462.33M+16.6%
2012$396.44M+14.8%
2011$345.25M-12.6%
2010$395.00M

Operating Income values are taken from IQVIA's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

IQVIA (IQV) most recent annual operating income stands at $2.29B (2025) – edged up 3.9% year-over-year.

IQVIA operating income has grown for 5 consecutive years, with a +25.6% compound annual growth rate over 2020–2025 (5 years).

Across the available history, operating income reached its high of $2.29B in 2025 and its low of $345.25M in 2011.

Within Healthcare, IQVIA (IQV) ranks 9th among 8 peers we track. The peer median for operating income is $22.84B.

IQVIA Operating Income by Year

IQVIA Operating Income 2025: $2.29B

IQVIA operating income in 2025 was $2.29B, edged up 3.9% from 2024. This figure represents the highest annual value in the available history.

IQVIA Operating Income 2024: $2.20B

IQVIA operating income in 2024 was $2.20B, grew 11.4% from 2023.

IQVIA Operating Income 2023: $1.98B

IQVIA operating income in 2023 was $1.98B, grew 9.9% from 2022.

IQVIA Operating Income 2022: $1.80B

IQVIA operating income in 2022 was $1.80B, grew 29.1% from 2021.

IQVIA Operating Income 2021: $1.39B

IQVIA operating income in 2021 was $1.39B.

See more financial history for IQVIA (IQV).

Sector peers — Operating Income

Companies in the same sector as IQVIA, ranked by their latest operating income.

CompanyOperating IncomeSector
Novo Nordisk A/S (NVO)$127.66BHealthcare
Eli Lilly and Company (LLY)$29.70BHealthcare
Merck & Co., Inc. (MRK)$26.78BHealthcare
Johnson & Johnson (JNJ)$25.60BHealthcare
AbbVie Inc. (ABBV)$20.09BHealthcare
UnitedHealth Group Incorporated (UNH)$18.96BHealthcare
AstraZeneca PLC (AZN)$13.74BHealthcare
Amgen Inc. (AMGN)$10.68BHealthcare

Frequently asked questions

What is IQVIA's operating income?

Latest reported operating income for IQVIA (IQV) is $2.29B (period ending December 31, 2025).

How has IQVIA operating income changed year-over-year?

IQVIA (IQV) operating income changed +3.9% year-over-year on the latest annual filing.

What is the long-term growth rate of IQVIA operating income?

IQVIA (IQV) operating income compound annual growth rate is +25.6% over the most recent 5 years available.

When did IQVIA operating income hit its highest annual value?

IQVIA operating income reached its highest annual value of $2.29B in 2025.

What was IQVIA operating income in 2024?

IQVIA (IQV) operating income in 2024 was $2.20B.

What was IQVIA operating income in 2025?

IQVIA (IQV) operating income in 2025 was $2.29B.

Metrics overview

Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.